vascular surgery

Cooper Aortic Center First in North America to Use New Investigational Device

Leave a Comment

For the second time in two years, the Cooper Aortic Center has introduced groundbreaking technology.

Vascular surgeons Frank Caputo, MD, and Jose Trani, MD, performed the first investigational  Nellix® EndoVascular Aneurysm Sealing System case in North America this morning. This new device, which uses a biocompatible polymer to seal aneurysms, is a game changer for the treatment of abdominal aortic aneurysms. Read more.

Cooper Implants First Drug-Eluting Stent for PVD in New Jersey

Leave a Comment
Cooper Vascular Surgeons implanted the first drug eluting stent for the treatment of Peripheral Vascular Disease (PVD) in the State of New Jersey. Zilver® PTX®(COOK MEDICAL, Bloomington, IN), the first drug-eluting stent (DES) stent of its kind, was recently approved for use by the Food and Drug Administration (FDA) and made available to only a select few centers of excellence in the country.

Cook Medical Releases Initial Results From Its STABLE Clinical Trial Endovascular Treatment of Aortic Dissection

Leave a Comment
The findings were presented by Dr. Joseph Lombardi at the 37th annual VEITHsymposium. The trial is the first and only one of its kind to focus on a device uniquely designed for the endovascular treatment of Type B aortic dissection. The system as a whole is an investigational device not available in the United States.

New Multi-Specialty Facility in Willingboro

Leave a Comment
We celebrated the opening of our new multi-specialty facility in Willingboro with a ribbon-cutting ceremony and tour on Monday night. The 11,000 square feet of practice space is in the heart of Burlington County and will offer patients an array of services, including: Podiatry, Vascular Surgery, Urology, Dermatology, Nephrology, Rheumatology as well as Primary Care.

Leading Vascular Surgeon Joins Cooper University Hospital

1 Comment
(Camden, New Jersey) Joseph V. Lombardi, M.D., joins the Department of Surgery at Cooper as the new Head of Vascular Surgery. He is a prominent vascular surgeon with expertise in minimally invasive endovascular therapy. Dr. Lombardi, is pioneering the treatment of thoracic aortic dissection with endovascular grafts and stents. He serves as Global Principal Investigator for the STABLE trial, investigating the use of endovascular therapy to treat complicated Type B Thoracic Aortic Dissection. “We are developing a masterful team of experts in surgery and Dr. Lombardi brings a talent unseen in our region,” said Jeffrey Carpenter, M.D., Chief of the Department of Surgery at Cooper.